Scaling a cell or gene therapy requires more than just science; it requires a robust logistics and manufacturing strategy.
Join industry veterans from Excellos, Lonza, Galapagos, and BCA as they share the unvarnished truth about navigating the path to commercialization. This discussion peels back the layers of complex supply chains to reveal what actually works in 2025.
Key Takeaways:
Strategic Sourcing: How to secure consistent starting material to reduce manufacturing failure rates.
Process Design: Emerging best practices for automating and closing your systems (Cocoon® Platform).
Risk Mitigation: Identifying the hidden scalability hurdles that delay clinical readiness.
Watch now to gain practical insights from the CDMO trenches—and stay tuned for future sessions unpacking the latest advances shaping the future of cell and gene therapy.
Contact us to continue the conversation and explore how Excellos can support your program.
